Evidence map›Paper›PMID 40411350›Full record

Trial reportOphthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)2025

Objective evaluation of fusional vergence after a vision therapy protocol in typical binocular vision.

Cristina Rovira-Gay, Marc Argiles, Clara Mestre, Marta Masdemont-Isern, Jaume Pujol

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Objective evaluation of fusional vergence after a vision therapy protocol in typical binocular vision.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cristina Rovira-GayCentre for Sensors, Instruments and Systems Development (CD6), Universitat Politècnica de Catalunya - BarcelonaTech (UPC), Barcelona, Spain.ORCID https://orcid.org/0000-0001-9765-1691
Marc ArgilesCentre for Sensors, Instruments and Systems Development (CD6), Universitat Politècnica de Catalunya - BarcelonaTech (UPC), Barcelona, Spain.ORCID https://orcid.org/0000-0001-5474-9832
Clara MestreCentre for Sensors, Instruments and Systems Development (CD6), Universitat Politècnica de Catalunya - BarcelonaTech (UPC), Barcelona, Spain.ORCID https://orcid.org/0000-0003-0053-550X
Marta Masdemont-IsernCentre for Sensors, Instruments and Systems Development (CD6), Universitat Politècnica de Catalunya - BarcelonaTech (UPC), Barcelona, Spain.
Jaume PujolCentre for Sensors, Instruments and Systems Development (CD6), Universitat Politècnica de Catalunya - BarcelonaTech (UPC), Barcelona, Spain.

Funding

Ministerio de Ciencia, Tecnología e Innovación PID2020-112527RB-I00Ministerio de Ciencia, Tecnología e Innovación PID2023-146101OB-I00Ministerio de Ciencia, Tecnología e Innovación TED2021-130409B-C54Next Generation Foundation
6 · The paper itself

Abstract

introductionVision therapy is an effective treatment option for binocular vision and accommodative anomalies. However, its effect on typical binocular vision is less documented. The aim of this study was to evaluate objectively the change in near fusional vergence amplitudes in adults with typical binocular vision after performing a vision therapy protocol.

methodsThirty-four adults were randomly classified into an experimental group (EG), who underwent a vision therapy protocol for 12 weeks, and a control group (CG), who received a placebo treatment for 12 weeks (Phase 1). In Phase 2, the CG performed the same therapy protocol as the EG. Fusional vergence amplitudes were measured objectively in a haploscopic set-up using smooth and step fusional vergence tests. The break points of positive and negative fusional vergence (PFV and NFV, respectively) were determined using a custom algorithm.

resultsAfter Phase 1, there were no significant differences between the groups for fusional vergences. After Phase 2, PFV and NFV increased significantly as measured with the smooth and step tests (p = 0.002 and p < 0.001 for NFV and p = 0.03 and p = 0.02 for PFV, respectively). These improvements were maintained after 1 month without any further intervention (all p > 0.05).

conclusionBased on these results, clinicians should consider that the vergence system cannot be trained beyond 2 and 5 Δ for NFV and PFV, respectively, when aiming to enhance vergence skills with vision therapy in patients without binocular dysfunctions.

Indexed as

Accommodation, OcularConvergence, OcularOrthopticsVision, BinocularAdultFemaleFollow-Up StudiesHumansMaleMiddle AgedTreatment OutcomeYoung Adultbinocular visioneye trackingfusional vergence amplitudesvision therapy

Identifiers

PMID40411350
PMCPMC12153028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.